title: Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia.
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Centre de Recherche en Cancérologie de Toulouse, Université Paul Sabatier, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Récher
authors.affiliation: Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France.
authors.forename: M C
authors.initials: MC
authors.lastname: Béné
authors.affiliation: Service d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
authors.forename: B
authors.initials: B
authors.lastname: Lioure
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Bordeaux, LHLCT-Inserm U1035, Université Bordeaux Segalen, Bordeaux, France.
authors.forename: A
authors.initials: A
authors.lastname: Pigneux
authors.affiliation: Département d'Hématologie, Institut Paoli-Calmettes, Marseille, France.
authors.forename: N
authors.initials: N
authors.lastname: Vey
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France.
authors.forename: J
authors.initials: J
authors.lastname: Delaunay
authors.affiliation: Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
authors.forename: I
authors.initials: I
authors.lastname: Luquet
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
authors.forename: M
authors.initials: M
authors.lastname: Hunault
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, France.
authors.forename: D
authors.initials: D
authors.lastname: Guyotat
authors.affiliation: Service d'Hématologie, Assistance Publique-Hopitaux de Paris Cochin, Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Bouscary
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
authors.forename: N
authors.initials: N
authors.lastname: Fegueux
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.
authors.forename: E
authors.initials: E
authors.lastname: Jourdan
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Tours, Tours, France.
authors.forename: S
authors.initials: S
authors.lastname: Lissandre
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Rennes, Rennes, France.
authors.forename: M
authors.initials: M
authors.lastname: Escoffre-Barbe
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, Nancy, France.
authors.forename: C
authors.initials: C
authors.lastname: Bonmati
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
authors.forename: E
authors.initials: E
authors.lastname: Randriamalala
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Clermont-Ferrand, Université Clermont 1, EA7283, Inserm CIC-501, Clermont-Ferrand, France.
authors.forename: R
authors.initials: R
authors.lastname: Guièze
authors.affiliation: Service d'Hématologie, Hôpital E. Muller, Mulhouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Ojeda-Uribe
authors.affiliation: Service d'Hématologie, Assistance Publique-Hopitaux de Paris Cochin, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Dreyfus
authors.affiliation: Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Nantes St Herblain, Nantes, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire de Grenoble, UMR 5525 CNRS, Université Joseph Fournier, Grenoble, France.
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
authors.forename: P
authors.initials: P
authors.lastname: Guardiola
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003630:Daunorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D008875:Middle Aged; D012074:Remission Induction; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D015255:Idarubicin; D003630:Daunorubicin